What is Cauldron?
Cauldron Ferm is at the forefront of biomanufacturing, specializing in precision fermentation to make bio-manufactured goods economically viable against traditional products. The company's proprietary hyperfermentation platform is designed to boost efficiency, reduce production costs, and enable continuous fermentation at industrial scales, moving beyond conventional batch methods. This advanced technology empowers clients to transition from development to large-scale production of ingredients and materials for diverse sectors, including food proteins, cosmetics, materials, chemicals, and fuels. Cauldron is recognized as a research-driven startup with global ambitions, focused on revolutionizing fermentation economics.
How much funding has Cauldron raised?
Cauldron has raised a total of $30M across 2 funding rounds:
Seed
$10.5M
Series A
$19.5M
Seed (2023): $10.5M, investors not publicly disclosed
Series A (2026): $19.5M led by Horizons Ventures, NGS Super, SOSV, Main Sequence Ventures, and In-Q-Tel
Key Investors in Cauldron
Horizons Ventures
Horizons Ventures focuses on investing in deep science and technology aimed at advancing humanity towards a significantly improved future. The company seeks to support innovative projects that have the potential to create transformative changes.
Main Sequence Ventures
Main Sequence is a venture capital firm focused on deeptech, collaborating with inventors who leverage their scientific expertise to create transformative industries. The firm aims to accelerate the growth of companies addressing significant global challenges.
In-Q-Tel
In-Q-Tel (IQT) is a not-forprofit strategic investment firm that acts as the U.S. national security communitys venture arm, identifying and investing in earlystage commercial technology companies worldwide.
What's next for Cauldron?
With its recent major strategic investment and substantial total funding, Cauldron is poised for significant expansion and technological advancement. The company's focus on scaling its proprietary hyperfermentation platform suggests a strategic push towards industrial-level production and broader market penetration across food, cosmetics, materials, and chemical sectors. Future developments will likely center on optimizing cost-efficiency and demonstrating the economic competitiveness of bio-manufactured goods compared to traditional alternatives, solidifying Cauldron's position as a leader in the biomanufacturing revolution.
See full Cauldron company page
